It continues to enjoy a strong rebound after a sell-off last week that investors seem to think was overdone.
News & Analysis: AMAG Pharmaceuticals
AMAG earnings call for the period ending June 30, 2019.
The drugmaker exited a key market, causing its top and bottom lines to tank in the second quarter.
A high-profile analyst questioned the company's recent FDA approval.
Two hope to pick up additional indications for existing blockbuster drugs, while another could score a big victory for a new drug.
AMAG earnings call for the period ending March 31, 2019.
AMAG earnings call for the period ending December 31, 2018.
The company's third-quarter financials did little to inspire confidence that its sales can withstand the launch of generic competition.
AMAG earnings call for the period ending September 30, 2018.
Find out why these two stocks have surged this year to see if there might be more gains ahead.